Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223620 · ClinicalTrials.gov registry record
A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction
A clinical trial of SBO - Small Bowel Obstruction, sponsored by Methodist Health System.
- Completed
- Registry status
- 504
- Enrollment target
- 1
- Study location
NCT06223620 is a study of SBO - Small Bowel Obstruction that has completed, run by Methodist Health System. The registered enrollment target is 504 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06223620, a study of SBO - Small Bowel Obstruction, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 504 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.
Conditions Studied
Interventions
- OTHER review performance of water soluble contrast
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 504 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06223620
The ClinicalTrials.gov registry entry for NCT06223620 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 504 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with SBO - Small Bowel Obstruction appearing as the primary indexed condition, and to 1 intervention - of which review performance of water soluble contrast is the first listed.
NCT06223620 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06223620 about?
NCT06223620 is a clinical study titled "A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction". The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.
What is the current status of trial NCT06223620?
This trial is currently completed. The enrollment target is 504 participants. The study started on 2018-07-30. Estimated completion is 2019-12-31.
What conditions does trial NCT06223620 study?
This clinical trial studies the following conditions: SBO - Small Bowel Obstruction.
What interventions are being tested in trial NCT06223620?
The interventions under investigation include: review performance of water soluble contrast (OTHER).
Who is sponsoring clinical trial NCT06223620?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06223620 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.